215 related articles for article (PubMed ID: 6457876)
1. Bone marrow transplantation across the major histocompatibility barrier in specific-pathogen-free mice: effects of intact versus T cell-depleted bone marrow on the expression of anti-host reaction in the recipient spleens.
Muto M; Sado T; Aizawa S; Kamisaku H; Kubo E
J Immunol; 1981 Dec; 127(6):2421-5. PubMed ID: 6457876
[No Abstract] [Full Text] [Related]
2. Bone marrow transplantation in inbred strains of mice. I. The failure of development of normal T cell function following allogeneic transplantation.
Trier L; Rubin B
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Oct; 82B(5):724-32. PubMed ID: 4139875
[No Abstract] [Full Text] [Related]
3. Kinetics of the anti-recipient cytotoxic cell response of mice with minor histocompatibility antigen graft-vs-host disease.
Hamilton BL; Parkman R
J Immunol; 1982 Jan; 128(1):376-9. PubMed ID: 6119344
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival of murine allogeneic bone marrow chimeras: effect of anti-lymphocyte serum and bone marrow dose.
Norin AJ; Emeson EE; Veith FJ
J Immunol; 1981 Feb; 126(2):428-32. PubMed ID: 7451985
[TBL] [Abstract][Full Text] [Related]
5. In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.
Blazar BR; Taylor PA; Vallera DA
J Immunol; 1994 Apr; 152(7):3665-74. PubMed ID: 8144942
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
[TBL] [Abstract][Full Text] [Related]
7. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
[TBL] [Abstract][Full Text] [Related]
8. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
Mathé G; Kiger N; Florentin I; Garcia-Giralt E; Martyre MC; Halle-Pannenko O; Schwartzenberg L
Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474
[No Abstract] [Full Text] [Related]
9. Prevention of graft-versus-host disease by Fab fragments derived from ALG.
Richie ER; Gallagher MT; Trentin JJ
Transplant Proc; 1973 Mar; 5(1):873-6. PubMed ID: 4144467
[No Abstract] [Full Text] [Related]
10. The double barrier in bone marrow transplantation.
van Bekkum DW
Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846
[No Abstract] [Full Text] [Related]
11. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
12. Treatment of donor bone marrow with OKT3 (PAN-T monoclonal antibody) for prophylaxis of graft-vs.-host disease (GvHD) in histocompatible allogeneic bone marrow transplantation (BMT): a pilot study.
Filipovich AH; McGlave P; Ramsay NK; Goldstein G; Kersey JH
J Clin Immunol; 1982 Jul; 2(3 Suppl):154S-157S. PubMed ID: 6752174
[TBL] [Abstract][Full Text] [Related]
13. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
[TBL] [Abstract][Full Text] [Related]
14. Immunology of fully H-2 incompatible bone marrow chimeras induced in specific-pathogen-free mice: evidence for generation of donor- and host-H-2 restricted helper and cytotoxic T cells.
Aizawa S; Sado T; Muto M; Kubo E
J Immunol; 1981 Dec; 127(6):2426-31. PubMed ID: 6170703
[No Abstract] [Full Text] [Related]
15. Bone marrow transplantation in rats across strong histocompatibility barriers by selective elimination of lymphoid cells in donor marrow.
Müller-Ruchholtz W; Wottge HU; Müller-Hermelink HK
Transplant Proc; 1976 Dec; 8(4):537-41. PubMed ID: 11584
[No Abstract] [Full Text] [Related]
16. Decreased graft-versus-host reaction and T cell cytolytic potential of beige mice.
Halle-Pannenko O; Bruley-Rosset M
Transplantation; 1985 Jan; 39(1):85-7. PubMed ID: 3880970
[No Abstract] [Full Text] [Related]
17. Comparison of the repertoire of T-cell lines and clones specific for minor histocompatibility antigens derived from immunized mice and from mice developing a graft-versus-host reaction.
Bruley-Rosset M; Miconnet I; Roger T; Seman M; Halle-Pannenko O
Transplant Proc; 1993 Feb; 25(1 Pt 1):94-5. PubMed ID: 8438503
[No Abstract] [Full Text] [Related]
18. Effect of the treatment of parental cells in vitro with anti-T antibody on bone marrow transplantation in F1 hybrid mice.
Hrubá A; Paluska E; Fricová V; Fiala J
Folia Biol (Praha); 1980; 26(5):338-50. PubMed ID: 7002637
[TBL] [Abstract][Full Text] [Related]
19. Regulation and suppression of graft-versus-host reaction.
Nouza K; Pichlílová
Allerg Immunol (Leipz); 1973; 19(2-4):279-89. PubMed ID: 4156162
[No Abstract] [Full Text] [Related]
20. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
